PIC/S Adapts EU IMP & QP Requirements In Updated GMP Guide
UK Considers Impact Of Revised EU Manufacturing Standards For Investigational Drugs
The international association of pharmaceutical inspectorates (PIC/S) has updated its GMP guide, aligning it with EU requirements to promote harmonization.
You may also be interested in...
A long-awaited regulation introduces major changes in the way that clinical trials are conducted across the EU, including a single application portal and new trial transparency requirements.
The UK regulatory agency, the MHRA, is planning to establish a “world-class sovereign regulatory environment” for clinical trials to support the development of new innovative medicines. In the first of two articles, we look at the MHRA’s proposals to slim down trial approval processes, lighten the safety reporting burden, and introduce greater transparency of trial registration and results.
International association of pharmaceutical inspectorates launches industry consultation on aligning with the one EU GMP provision it spurned years ago.